692 The difficult asthma multi-disciplinary clinic: silver linings of the COVID cloud

Abstract

<h3>Background</h3> An estimated 5–10% of children with asthma have problematic severe asthma, defined as asthma which is poorly controlled (chronic symptoms, episodic exacerbations, continued requirement for short-acting β agonists) despite a daily dose of at least 800 μg budesonide or equivalent for 6 months or longer. Such patients should be referred to a specialist difficult asthma team in a tertiary care, in order to facilitate systematic specialist assessment and a multi-disciplinary approach to management. <h3>Objectives</h3> As with most outpatient services, the delivery of paediatric difficult asthma (DA) clinics was disrupted by the COVID-19 pandemic. Teams were required to restructure clinics and operating procedures, in order to optimise patient care despite the restrictions on face-to-face appointments. This study aimed to assess the impact that the COVID-19 pandemic had on the initial assessment of patients referred to the paediatric DA clinic at a tertiary care, specifically in relation to being seen by the appropriate multi-disciplinary team (MDT) members and having relevant investigations completed. <h3>Methods</h3> The electronic notes database was interrogated to provide a list of children and young people with asthma referred to the paediatric DA clinic between 1/9/2016 and 31/12/2020. In total 144 patients were identified, and their electronic medical records were retrospectively reviewed. Patients were considered to have been seen ‘pre-COVID’ if their initial appointment in the paediatric DA clinic occurred prior to 23/03/2020, and considered to have been seen ‘post-COVID’ if their initial appointment was on or after 23/03/2020. <h3>Results</h3> Of the total 144 patients, 130 were initially seen in the paediatric DA clinic pre-COVID and 14 were initially seen post-COVID. In the post-COVID group, fewer patients had fractional exhaled nitric oxide (FeNO) (71%) and spirometry (57%) as part of their initial work-up. In the pre-COVID group, 85% had FeNO measured and 96% had spirometry. This was in contrast to the proportion of patients having a physiotherapy and psychology assessment; in the post-COVID group, 64% had physiotherapy review and 50% had psychology review following their difficult asthma referral, compared to 52% and 26%, respectively, in the pre-COVID group. The wait for initial specialist assessment after being seen in the DA clinic for the first time was also reduced in the post-COVID cohort. The median wait for physiotherapy and psychology assessment decreased from 91 and 180 days in the pre-COVID group to 70 and 35 days, respectively, in the post-COVID group. <h3>Conclusions</h3> Unsurprisingly given strict restrictions on in-person appointments and aerosol generating procedures, assessment of FeNO and spirometry was lower in patients first seen in the DA clinic post-COVID. However, improvements were seen in relation to physiotherapy and psychology assessment in the post-COVID group, as the physiotherapist and psychologist were able to attend more DA clinics to see new patients at their first appointment. This highlights that changes to working in response to the COVID-19 pandemic can actually help to streamline services and promote early input from the wider MDT when managing patients with problematic severe asthma.